Loading market data...

Corona Remedies IPO

Pharma - Listed on 15 December 2025

+38.4% listing gain
Issue Price (Upper)
Rs 1,062
Listing Price
Rs 1,470
Closing Price (NSE)
Rs 1,438.4
Total Subscription
137.04x

Corona Remedies IPO listing summary

Corona Remedies (Pharma) closed its IPO window in 2025 and listed on NSE and BSE on 15 December 2025 at an upper band issue price of Rs 1062, opening at Rs 1470 for a listing gain of +38.4% and closing day one at Rs 1438.4 (+35.4% on closing basis). The IPO was subscribed 137.04x overall - QIB 278.52x, HNI/NII 208.88x, Retail 28.73x. The total issue size was Rs 655.37 Cr (Fresh Issue Rs 0 Cr, OFS Rs 655.37 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+38.42%
Listing Gain (Close)
+35.44%
Day Change After Listing
-2.98%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB278.52x
HNI / NII208.88x
Retail28.73x
Overall137.04x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 10.62x
Day 29.33x
Day 3 (Final)137.04x

Corona Remedies IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 362+34.09%
Day 2Rs 362+34.09%
Day 3Rs 280+26.37%
Day 4Rs 260+24.48%
Day 5Rs 260+24.48%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
24.5%-34.1%
IPOGyani AI Prediction
-
Actual Listing Gain
+38.4%

Issue & financials

Issue SizeRs 655.37 Cr
Fresh IssueRs 0 Cr
OFSRs 655.37 Cr
IPO PE43.47
Peer / Sector PE36.28
PE vs Sector Ratio1.40
Latest EBITDA (Cr)20.55
Debt / Equity0.10

Market context at listing

How the broader market moved around the Corona Remedies IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return+0.01%
Nifty 1W Return-0.00%
Nifty 1M Return+0.02%
Nifty during IPO window-0.01%

Corona Remedies IPO - FAQs

What was the listing gain of Corona Remedies IPO?

Corona Remedies IPO listed at +38.4% versus the upper issue price of Rs 1,062 on 15 December 2025.

How many times was Corona Remedies IPO subscribed?

Corona Remedies IPO was subscribed 137.04x overall. QIB portion was subscribed 278.52x, HNI / NII 208.88x and Retail 28.73x.

What was the IPO GMP for Corona Remedies?

IPO GMP started at Rs 362 on Day 1 and moved to Rs 260 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2025

Browse listed IPOs by year